Novo Nordisk Gulf Appoints Venkat Kalyan as General Manager

Novo Nordisk Gulf Appoints Venkat Kalyan as General Manager
July 21, 2026

LATEST NEWS

Novo Nordisk Gulf Appoints Venkat Kalyan as General Manager

Dubai, UAE – 21 July 2026: Novo Nordisk has appointed Mr. Venkat Kalyan as General Manager for Novo Nordisk Gulf. The appointment reinforces the company’s confidence in the Gulf’s evolving healthcare ecosystem and the UAE’s growing role as a strategic centre for medical research, innovation, and partnership-led growth.

In this role, Mr. Kalyan will oversee Novo Nordisk’s operations across the UAE, Qatar, Kuwait, Bahrain, Oman, and Yemen. He will focus on strengthening healthcare partnerships, advancing innovation, and improving outcomes for patients living with chronic diseases.

Mr. Kalyan commented: “The Gulf markets hold real potential and are exceptionally well positioned to lead the next phase of healthcare transformation. I look forward to building on Novo Nordisk’s strong foundation in the region and working closely with all our healthcare stakeholders to improve outcomes for patients.”

Mr. Kalyan brings nearly 30 years of experience in the pharmaceutical and healthcare sector, including 18 years at Novo Nordisk, most recently as General Manager of the Gulf Emerging Markets Cluster. His prior leadership experience spans across diverse markets such as India, Switzerland, Denmark, Middle Africa, South Africa and Gulf countries.

With its rapidly evolving healthcare landscape, the Gulf markets have become an integral part of Novo Nordisk’s global growth strategy, as the company renews its commitment to expanding its impact across the region and advancing accessible and sustainable patient care systems for these communities.

About Novo Nordisk

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 67,900 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com, FacebookInstagramXLinkedIn and YouTube.  

Share this post:

POLL

Who Will Vote For?

Other

Republican

Democrat

RECENT NEWS

A Guide to What’s On Across the Next Two Weeks in Abu Dhabi

A Guide to What’s On Across the Next Two Weeks in Abu Dhabi

ECC Contracting’s Record AED 4.73 Billion Project Wins

ECC Contracting’s Record AED 4.73 Billion Project Wins

ADEK Launches Student Readiness Program for Global Success

ADEK Launches Student Readiness Program for Global Success

Dynamic Country URL Go to Country Info Page